SCHEMBL7303975

SCHEMBL7303975

O=C(N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCc1ccno1)OCc1ccno1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.48
CYP3A4 P08684 9/20 0.43
TACR1 P25103 3/20 0.43
MEN1 O00255 1/20 0.43
SLC22A2 O15244 1/20 0.43
SLC22A1 O15245 1/20 0.43
ABCC3 O15438 1/20 0.43
ABCC4 O15439 1/20 0.43
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
SLCO2B1 O94956 1/20 0.43
ABCB11 O95342 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PGR P06401 1/20 0.43
ABCB1 P08183 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8607076 1.00 CTRB1 (0.48) CTRB1CYP3A4TACR1MEN1SLC22A2
SCHEMBL7092577 0.89 CTSB (0.43) CTRB1CYP3A4TACR1ALDH1A1CTSB
SCHEMBL7646401 0.89 CTSB (0.43) CTRB1CYP3A4TACR1ALDH1A1CTSB
SCHEMBL4950328 0.85 CTRB1 (0.65) CTRB1CYP3A4TACR1ALDH1A1CTSB
SCHEMBL7308773 0.84 CTRB1 (0.49) CTRB1CYP3A4TACR1MEN1SLC22A2
SCHEMBL7303656 0.84 CTRB1 (0.57) CTRB1CYP3A4TACR1MEN1SLC22A2
SCHEMBL9015424 0.84 CTRB1 (0.57) CTRB1CYP3A4TACR1MEN1SLC22A2
SCHEMBL7184965 0.83 CYP3A4 (0.49) CYP3A4TACR1MEN1SLC22A2SLC22A1
SCHEMBL7298842 0.82 CTRB1 (0.50) CTRB1CYP3A4TACR1MEN1SLC22A2
SCHEMBL7357618 0.82 CYP3A4 (0.64) CTRB1CYP3A4TACR1MEN1SLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed